JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2012, 61(3):127-129

High active potential antimycobacterial agents against Mycobacterium avium

Karel Waisser1,*, Jiří Kuneš1, Jiřina Stolaříková2
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Inorganic and Organic Chemistry
2 Regional Institute of Public Health

Derivatives of 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dione are active against Mycobacterium avium when substituted in position 7 with a methyl. One or two carbonyl groups have to be replaced with a thioxo group. High active derivatives are the compounds without substitution on the phenyl, or those substituted on the phenyl in position 3 or 4 with chlorine, bromine or a methyl. The substitution in position 3 and 4 with two atoms of chlorine lowers the activity. The compounds are active against INH resistant strains. We synthesized other 44 derivatives with a similar structure of the compounds as in the paper but substituted in position 7 with other substituents (chlorine, bromine methoxy). The activity against M. avium was poor. It can be concluded that a new group of compounds with an excellent activity against M. avium has been found.

Keywords: benzoxazine; thioxo group; Mycobacterium avium; antimycobacterial activity

Received: March 21, 2012; Accepted: April 24, 2012; Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Waisser K, Kuneš J, Stolaříková J. High active potential antimycobacterial agents against Mycobacterium avium. Čes. slov. farm. 2012;61(3):127-129.
Download citation

References

  1. WHO (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response, 2010 (cit. 2010-10-14). Available from: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf.
  2. Tortoll E. Clinical manifestations of nontuberculous mycobacteria infections. Journal Compilations, European Society of Clinical Microbiology and Infection Diseses 2009; 906-910. Go to original source... Go to PubMed...
  3. Waisser K., Bureš O., Holý P., Kuneš J., Oswald R., Jirásková L., Pour M., Klimešová V., Palát K. Jr., Kaustová J., Dahse H.-D., Möllman U. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones. Pharmnazie 2003; 58: 83-94. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.